Companies/US/MPLT

MAPLIGHT THERAPEUTICS, INC.

Last · —$7.81-0.065 (-0.83%)live · yahoo · 1s ago
Vol 450.9K ≈ 3.52M
Market cap$434.05M—
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session

Issuer

Legal nameMAPLIGHT THERAPEUTICS, INC.
HQUnited States (US)
ListingUS MPLT
ISINUS56565P1030
SectorHealthcare
IndustryBiotechnology & Medical Research
SIC2834
CurrencyUSD
Entity registrysec:0001770069
CIK0001770069
Websitemaplightrx.com
LinkedIn
Employees133
AddressMapLight Therapeutics, Inc. 800 Chesapeake Drive 94063, Redwood City
Loading chart…

Upcoming earnings

1 event
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$1.17
Est. revenue
0
View upcoming earnings →

Press & signals

2 recent
  • GlobeNewswire

    MapLight Therapeutics Celebrates Co-Founder Dr. Karl Deisseroth on Receipt of 2026 Nobel Prize in Physiology or Medicine for the Development of Optogenetics

  • GlobeNewswire

    MapLight Therapeutics Announces $150 Million Private Placement Financing

Documents

FormReporting forFiledFlags
424B3MapLight Therapeutics, Inc. — 424B3
—2026-09-230
S-1/AMapLight Therapeutics, Inc. — S-1/A
—2026-09-180
4
2026-09-162026-09-180
S-1MapLight Therapeutics, Inc. — S-1
—2026-09-090
4
2026-08-172026-08-190
Showing 5 of 19 filings